<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9700112</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20453</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Chem.</journal-id>
<journal-title-group>
<journal-title>Biological chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1431-6730</issn>
<issn pub-type="epub">1437-4315</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26760308</article-id>
<article-id pub-id-type="pmc">4753800</article-id>
<article-id pub-id-type="doi">10.1515/hsz-2015-0270</article-id>
<article-id pub-id-type="manuscript">NIHMS756689</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
<aff id="A1">Burke Medical Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 785 Mamaroneck Ave., White Plains, NY10605, USA</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author, <email>Jiz2010@med.cornell.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>1</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2017</year>
</pub-date>
<volume>397</volume>
<issue>3</issue>
<fpage>215</fpage>
<lpage>222</lpage>
<!--elocation-id from pubmed: 10.1515/hsz-2015-0270-->
<abstract>
<p id="P1">In postmitotic neurons, the activation of RAS family small GTPases regulates survival, growth and differentiation. Dysregulation of RAS or its major effector pathway, the cascade of RAF-, mitogen-activated and extracellular-signal regulated kinase kinases (MEK), and extracellular-signal regulated kinases (ERK) causes the Rasopathies, a group of neurodevelopmental disorders whose pathogenic mechanisms are the subject of intense research. I here summarize the functions of RAS – RAF – MEK – ERK signaling in neurons <italic>in vivo</italic>, and discuss perspectives for harnessing this pathway to enable novel treatments for nervous system injury, the Rasopathies, and possibly other neurological conditions.</p>
</abstract>
<kwd-group>
<kwd>axon</kwd>
<kwd>MAP kinase</kwd>
<kwd>neuron</kwd>
<kwd>Rasopathies</kwd>
<kwd>regeneration</kwd>
<kwd>sensory function</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>